Skip to main content

Rainier Acquisition Corp

corporate_fare Company Profile

Rainier Acquisition Corp

RNAQ·NASDAQ·Life Sciences·CIK 0002147219

Rainier Acquisition Corp is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), incorporated in 2023 and headquartered in New York, New York. The company's primary purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Rainier Acquisition Corp was formerly known as Chardan Healthcare Acquisition 4 Company and changed its name in March 2026. The company aims to identify and partner with category-defining life sciences companies to create long-term public-market value through scientific rigor, global sourcing, and disciplined execution. Dr. Gbola Amusa serves as the Chief Executive Officer and a board member, bringing over 25 years of experience in evaluating, investing in, financing, operating, and advising life sciences companies. Dr. Isaac Manke is the Co-Founder and Chairman, with over 20 years of experience in investing in, evaluating, financing, and advising biotechnology companies. Sources: [1] https://stockanalysis.com/stocks/rnaq/company/ [2] https://www.fool.com/quote/nasdaq/rnaqu/ [3] https://www.trade-ideas.com/stock-info/RNAQ/ [4] https://www.sofi.com/invest/stock/RNAQ/ [5] https://www.lighthorse.io/tickers/rnaq [6] https://www.investing.com/equities/rainier-acquisition-company-profile [7] https://za.investing.com/equities/rainier-acquisition-company-profile [8] https://rainier-acq.com/

Rainier Acquisition Corp (NASDAQ:RNAQ) is a publicly traded company in the Life Sciences sector.

Short Interest & Short Volume

3.47 days to cover

FINRA reported short interest of 2,415 shares in RNAQ as of the October 30, 2026 settlement, a 10.4% decrease from the prior period — about 3.5 days to cover at its recent average daily volume. On November 19, 2026, 73.8% of RNAQ volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,415 shares as of October 30, 2026
Change vs prior period▼ 10.4%
Days to cover3.47 at avg daily volume of 695
Daily short volume (FINRA facilities)73.8% of 42 shares on November 19, 2026
5-day average short volume43.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$10.02 +0.40% today
Market cap
$117.49M
Live data · 2026-11-20 20:23 UTC · Market open

show_chartPrice Chart

Loading chart...

feed RNAQ - Latest Insights

Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets